Drug intelligence / Profile preview

Huoluo Zhitong Wan

Development stage: Unknown
Lead developer: Guangzhou Chen Li Ji Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Huoluo Zhitong Wan is a traditional Chinese medicine (TCM) herbal formulation manufactured by Chen Li Ji (Guangzhou Baiyunshan Chen Li Ji Pharmaceutical Co., Ltd.). It is primarily indicated for the treatment of orthopedic and musculoskeletal pain, particularly conditions associated with rheumatism, joint pain, and limb numbness. In the framework of traditional Chinese medicine, the formulation is designed to expel wind, remove dampness, and activate the collaterals to alleviate pain and restore mobility. As a marketed product from one of China's oldest pharmaceutical manufacturers, it is available in oral pill form and is categorized under orthopedic pain medications.

Brand names: Chen Li Ji
Other names: 活络止痛丸Huoluo Zhitong Pills

Beyond the preview

Go deeper on Huoluo Zhitong Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoluo Zhitong Wan.

Explore the full profile